MEDICAL TECHNOLOGY M&A MARKET DYNAMICS
- M&A activity in the Medical Technology sector stayed on par with the previous two quarters, with 105 announced transactions. Volume is significantly lower than the same quarter last year, with 135 deals in Q4 2024.
- Headline value this quarter was driven by two megadeals; Abbott’s $23 billion acquisition of Exact Sciences, and the $18.3 billion take-private of Hologic by Blackstone and TPG.
- Strategic acquirers continue to anchor the market, but their approach has shifted toward targeted capability providers and platform tuck-ins, rather than broad portfolio expansion. Potential valuation softness in 2026 is expected to intensify competition for quality assets.
- Deal activity in 2025 was led by the Therapeutic Device segment (21%), with Equipment and Service each accounting for 15% of transactions and Consumables & Disposables comprising 13%.
Medical Technology M&A Pulse – Q3 2025
M&A activity in the Medical Technology sector remained subdued in Q3 2025 at 102 announced transactions, significantly below the 165 deals recorded in Q3 2024.
Medical Technology M&A Pulse – Q2 2025
M&A activity in the Medical Technology sector remained subdued in Q2 2025, with 104 announced transactions, a decline from the 128 deals recorded in Q2 2024.
Medical Technology M&A Pulse – Q1 2025
MEDICAL TECHNOLOGY M&A MARKET DYNAMICS M&A activity in the Medical Technology sector was relatively soft in Q1 2025, with 118 announced transactions, falling short of the 135 deals recorded in Q1 2024. To keep pace with the relatively stable deal volumes seen over the past three years on a yearly basis, the market will need…
Medical Technology M&A Pulse – Q4 2024
MedTech M&A deal volume in 2024 remained consistent with 2023 levels despite headwinds from rising input costs and regulatory shifts over the past year.
Medical Technology M&A Pulse – Q3 2024
Interest rate cuts bring a breath of fresh air to the Medical Technology sector, as more capital becomes available for acquisitions.